Sutro Biopharma, Inc. (STRO) vs Yarrow Bioscience, Inc (YARW)
- Sutro Biopharma, Inc. STRO 10.87 −5.15%
- Yarrow Bioscience, Inc YARW 18.78 −6.10%
Sutro Biopharma, Inc. and Yarrow Bioscience, Inc are both Biotechnology companies. Sutro Biopharma, Inc. and Yarrow Bioscience, Inc are of similar size ($190.0M and $188.8M). Yarrow Bioscience, Inc grew revenue faster over the last twelve months: 1.26% against −56.3%. Sutro Biopharma, Inc. has the higher net margin (−395.3% vs −3,881.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Sutro Biopharma, Inc. leads on 9 and Yarrow Bioscience, Inc on 5.
Valuation
Profitability
| Metric | STRO | YARW | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (319.57%) | (4,134.44%) | 0.00% |
| Net margin | (395.25%) | (3,881.54%) | 0.00% |
| Free cash flow margin | (318.63%) | (3,513.07%) | 0.00% |
| Return on equity | 266.76% | (61.40%) | (56.36%) |
| Return on assets | (79.08%) | (54.77%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack